spacer
home > pmps > spring 2019 > digitising the chain
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Digitising the Chain

The pharmaceutical and medical supplies sector, like every other, has changed almost beyond recognition in the past decade, thanks to the development and availability of data-driven systems. For example, artificial intelligence is widely seen as the next frontier in R&D, helping to speed up clinical trials, improve their validity, and get drugs to market sooner.

Production, warehousing, and distribution have undergone a similar transition, with automation and data insights increasingly being used to speed up processes and improve traceability and compliance. Digital processes now impact every aspect of the modern supply chain, from Tier 1 drugs manufacturers to smallmedium enterprises supplying sterile packaging or components.

System Selection

Agile systems enable pharma companies to meet the requirements and challenges of a rapidly evolving sector. The availability of real-time data means production managers can make better informed decisions, moving from merely reporting what is happening on the shop floor to driving positive action. Its application is akin to researchers conducting clinical trials using data from multiple sources, such as wearable technology, rather than relying on limited and/or historic results to deliver more rigorous results faster.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rod Schregardus is a Consultant Manager at pharma software expert, Access Group. Specialising in global new business for Access’ advanced planning and scheduling software, Access Orchestrate, Rod boasts over 20 years in the manufacturing industry and works with pharma companies across the world.
spacer
Rod Schregardus
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Huge CPhI & P-MEC China a direct result of surging manufacturing

Shanghai, 22 July, 2019:CPhI and P-MEC China – organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, and Shanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market in China continues to grow. The three-day Shanghai event featured 3,200+ exhibiting companies, spanning the entire pharma supply chain, and provides a strong indication of the market’s overall growth patterns and future development.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: 2nd Quarter 2014

Synergy Research Group

The Ministry of Health of Russian Federation approved 194 new clinical trials of all types including local and bioequivalence studies during the 2nd Quarter of 2014 (3% less than at the same period of the last year). The main contribution to the total number of studies was made by multinational multi-center clinical trials (MMCT) and the number of these studies stayed the same as in Q2 2013 – 81 studies. The number of bioequivalence studies (BE) decreased from 76 studies in Q2 2013 to 59 in Q2 2014, a 22% decrease from last year’s figure. The number of local clinical trials (LCT) increased from 42 in Q2 2013 to 54 clinical trials in Q2 2014.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement